Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

INSYS Therapeutics Inc. (INSY)

4.7649   0.375 (8.54%) 03-19 12:55
Open: 4.43 Pre. Close: 4.39
High: 4.94 Low: 4.41
Volume: 901,312 Market Cap: 355M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.434 - 4.451 4.451 - 4.471
Low: 4.016 - 4.034 4.034 - 4.053
Close: 4.356 - 4.385 4.385 - 4.419

Technical analysis

as of: 2019-03-19 12:29:28 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 6.59     One year: 7.84
Support: Support1: 3.92    Support2: 3.26
Resistance: Resistance1: 5.64    Resistance2: 6.71
Pivot: 5.44
Moving Average: MA(5): 4.35     MA(20): 5.57
MA(100): 5.44     MA(250): 6.72
MACD: MACD(12,26): -0.12     Signal(9): 0.10
Stochastic oscillator: %K(14,3): 19.47     %D(3): 12.58
RSI: RSI(14): 46.17
52-week: High: 11.65  Low: 3.35  Change(%): -23.6
Average Vol(K): 3-Month: 109013  10-Days: 129140

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
INSY has closed above bottom band by 32.4%. Bollinger Bands are 53.8% wider than normal. The large width of the bands suggest high volatility as compared to INSY's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Thu, 14 Mar 2019 17:12:10 Z
Insys Plunges on Auditor's Concern About Insufficient Funds

Wed, 13 Mar 2019 22:09:25 Z
Why Insys Therapeutics Shares Crashed Today

Wed, 13 Mar 2019 22:09:02 Z
Why Express, Roku, and Insys Therapeutics Slumped Today

Wed, 13 Mar 2019 20:41:45 Z
Mid-Afternoon Market Update: Crude Oil Up 2.6%; Synchronoss Technologies Shares Drop After Q4 Results

Fri, 08 Mar 2019 20:08:09 Z
Insys Therapeutics (INSY) Q4 2018 Earnings Conference Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 74.43
Shares Float (M) 73.77
% Held by Insiders 0.90
% Held by Institutions 24.90
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.380
EPS Est. Current Year -0.330
EPS Est. Next Year -0.190
EPS Est. Next Quarter -0.120
Forward EPS -0.070
Book Value (p.s.) 3056.900
PEG Ratio -0.08
Profit Margin
Operating Margin -132.26
Return on Assets (ttm) -52.8
Return on Equity (ttm) -1077.6
Qtrly Rev. Growth -48.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -55.99
Levered Free Cash Flow (M) -126.53

Stock Valuations

P/E -3.52
P/E Growth Ratio 0.11
P/S 325882720.00
P/CF -6.46

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2015-06-08
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.